News

Psoriasis trials are among the least diverse within dermatology, with participants predominantly being white men.

Dematology Times' Editor in Chief interviews Adelaide Hebert, MD, who will be honored at the AAD 2025 Legacy Celebration for her impact on pediatric dermatology.

A new survey reveals widespread misunderstanding and lack of effective treatments in chronic hand eczema.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

In a conversation with Kristy Hamilton, MD, FACS, she spoke about the recent aesthetic trend and how clinicians can align with new patient expectations.

Research suggests that rebalancing the skin microbiome with pre-, post-, and probiotics may improve AD symptoms.

Experts discussed pediatric atopic dermatitis, treatment innovations, disease burden, and the latest topical and systemic therapies in a DermView video series.

When compared to corticosteroids alone, the combination therapy reduced disease severity and improved the skin barrier.

Celebrate Women’s History Month 2025 with insights from leading female dermatologists and expert coverage from the AAD Annual Meeting in Orlando.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Single-use packaging and excess sample distribution contribute to environmental harm, necessitating a shift in industry practices.

Phase 3 trial results presented at AAAAI/WAO 2025 highlight dupilumab's efficacy in reducing itch severity and urticaria activity in CSU patients.

A new qualitative analysis revealed which type of content on acne is trending on the social media platform and how clinicians should respond.

APG990 showed a 60-day half-life and favorable safety, supporting potential 3-6 month maintenance dosing for atopic dermatitis.

“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.

Explore the top headlines of the week including insights from Terri Philips, MD, FAAP, innovations in wound healing, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about Arcutis’ sNDA for roflumilast in pediatric AD, the current clinical and aesthetic applications of snail mucin, positive results from the CHE delgocitinib trial in China, and more.

This week, we feature top articles from our sister publications on recent clinical trials, practice management, and innovative technology.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of March.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the month including the expanding role of NPs and PAs, a guide to 2025 conferences, and expert insights from Paul Friedman, MD.

Share your thoughts by answering today’s poll and read about these popular aesthetic techniques for lips.

Review our content from the month of February that recognizes patients and clinicians with skin of color.

At a recent Dermatology Times Case-Based Roundtable event, James Q. Del Rosso, DO, discussed the limitations of topical corticosteroids and the benefits of nonsteroidals.

Learn more about the in-depth topics covered in the February 2025 print issue of Dermatology Times.

Today, Dermatology Times recognizes Rare Disease Day in an effort to amplify the voices of the over 300 million individuals affected by rare diseases.

Catch up on dermatology news, highlights, and insights from the past 24 hours.